How to improve at managing conflicts of interest in national pharmaceutical systems by WHO & USAID MTaPS
The World Health Organization in collaboration with the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) program is organising a webinar on Managing Conflicts of Interest in National Pharmaceutical Systems.
This webinar aims to raise awareness of the need for better management of conflict of interest in public pharmaceutical committees and to share information on practical steps to prevent and manage conflicts of interest.
Whereas the Sustainable Development Goals highlight the importance of good governance for realising development goals, including universal health coverage, it is usually not the case in reality, particularly in low- and middle-income countries (LMICs).
Good governance should be able to deal with the effective prevention and management of conflicts of interest that may compromise the integrity of decision-making in the public pharmaceutical sector. However, adverse outcomes can occur throughout the pharmaceutical system, including poor quality of care and harm to individuals, wastage of valuable health system resources, and a lack of trust in government institutions. Moreover, conflicts of interest in the public pharmaceutical sector are common in high- and low-income countries alike and are often not well understood.